-
July 30: The Week in Cancer News
Healthy lifestyle habits can reduce risk of cancer, and less treatment may be adequate for some children with ALL.
by Marci A. Landsmann
-
Open Medical Records: Pros and Cons
Patients now have full access to their online medical records. What are the benefits and downsides?
by Jen Tota McGivney
-
July 23: The Week in Cancer News
Two studies on access to opioids identify disturbing patterns, and Keytruda before and after surgery helps some breast cancer patients.
by Kevin McLaughlin
-
Remote Care
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs' value for cancer patients undergoing treatment.
by Jon Kelvey
-
July 16: The Week in Cancer News
A study measures the global impact of alcohol on cancer incidence, and the FDA approves treatments for multiple myeloma and urothelial cancer.
by Bradley Jones
-
Moving Away From the Maximum Tolerated Dose
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
-
July 9: The Week in Cancer News
Study shows cancer centers can improve coordination with physicians' practices in their networks, and cancer death rates in U.S. continue to decline.
by Marci A. Landsmann
-
July 2: The Week in Cancer News
A study sheds light on the link between red meat consumption and colorectal cancer, and mRNA COVID-19 vaccines are effective in most cancer patients.
by Kevin McLaughlin
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles